It’s been a long time coming, but it looks like the FDA is getting around to providing guidance to the healthcare industry around social media. Granted that realtime online conversations and the heavily regulated drug industry aren’t the most obvious of bedfellows, but it’s a reality and it’s here to stay.
It looks like the FDA is taking a stand (sort of), having recently released draft guidelines for regulated healthcare companies on what they call Interactive Promotional Media (pdf) . While not a comprehensive document about managing all social media content and channels, it is an important start on the road to clarity and the most direct guidance that the FDA has issued on the topic so far. Read more on the blog at Twist (our sister company at W2O Group) where colleague, Colin Foster, breaks it down.